|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| A61K 9/0007 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/1611 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 9/1623 | (2013.01) | ||
| A61K 9/46 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61K 9/485 | (2013.01) | ||
| A61K 9/4858 | (2013.01) | ||
| A61K 9/4866 | (2013.01) | ||
| A61K 31/47 | (2013.01) |
| (11) | Patento numeris | 3384901 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17164761.3 |
| Europos patento paraiškos padavimo data | 2017-04-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-08-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (72) |
NOGUEIRAS NIETO, Luis , ES
ÁLVAREZ FERNÁNDEZ, Lisardo , ES
KUMAR, Rohit , ES
VELADA CALZADA, José , NL
|
| (73) |
Synthon B.V. ,
Microweg 22, 6545 CM Nijmegen,
NL
|
| (54) | PHARMACEUTICAL COMPOSITION COMPRISING LENVATINIB MESYLATE |
| PHARMACEUTICAL COMPOSITION COMPRISING LENVATINIB MESYLATE |